Cocrystal Pharma to Participate in a Fireside Chat at the Zacks SCR Life Sciences Virtual Investor Forum on March 13, 2025

Rhea-AI Summary

Cocrystal Pharma (Nasdaq: COCP) has announced its participation in the Zacks SCR Life Sciences Virtual Investor Forum scheduled for March 13, 2025. The company's management will engage in a fireside chat at 11:30 a.m. Eastern time (8:30 a.m. Pacific time), hosted by Zacks Small Cap Research Senior Analyst David Bautz, PhD.

Investors can pre-register for the virtual presentation through Cocrystal's website and will have the opportunity to:

• Submit questions during the live event
• Request one-on-one meetings with management via the 'Book A Meeting' button
• Access a replay of the event through the company's website

BOTHELL, Wash., March 06, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that management will participate in a fireside chat at the Zacks SCR Life Sciences Virtual Investor Forum on Thursday, March 13, 2025 at 11:30 a.m. Eastern time (8:30 a.m. Pacific time). The fireside chat will be hosted by Zacks Small Cap Research Senior Analyst David Bautz, PhD.

Pre-register for Cocrystal’s virtual presentation is available on the Cocrystal website here. Investors will have the opportunity to submit questions online during the live event and can request a one-on-one meeting with management by selecting the “Book A Meeting” button on Cocrystal’s presentation page. A replay of the event will be available on the Cocrystal website here.

About Virtual Investor Conferences^®

Virtual Investor Conferences is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors. Learn more about the event at www.virtualinvestorconferences.com.

About Cocrystal Pharma, Inc.

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs. For further information about Cocrystal, please visit www.cocrystalpharma.com. 

Contact:
Alliance Advisors IR
Jody Cain
310-691-7100
jcain@allianceadvisors.com

# # #

FAQ

When is Cocrystal Pharma (COCP) presenting at the Zacks SCR Life Sciences Virtual Investor Forum?

Cocrystal Pharma will present on March 13, 2025, at 11:30 a.m. Eastern time (8:30 a.m. Pacific time).

How can investors participate in Cocrystal Pharma's (COCP) virtual presentation?

Investors can pre-register through Cocrystal's website, submit questions during the live event, and request one-on-one meetings with management.

Who will host the fireside chat with Cocrystal Pharma (COCP)?

The fireside chat will be hosted by Zacks Small Cap Research Senior Analyst David Bautz, PhD.

Will there be a replay available of Cocrystal Pharma's (COCP) presentation?

Yes, a replay of the event will be available on Cocrystal's website.